Werner Milton H. Insider Trades

Insider Trading History

Track insider trading activity for Werner Milton H.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
President And CEO
Holding Value $74.7k 45,000 shares
Last Trade
Jan 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$340k 121,144 shares
$2.81
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
President And CEO
Holding Value $0 0 shares
Last Trade
Jan 21, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$361k 128,430 shares
$2.81
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
President And CEO
Holding Value $8.82M 5,315,056 shares
Last Trade
Jan 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$38.5M 11,582,471 shares
$3.32
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
10% owner, President And CEO
Holding Value $74.7k 45,000 shares
Last Trade
Apr 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$97.2k 45,000 shares
$2.16
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
10% owner, President And CEO
Holding Value $349k 210,000 shares
Last Trade
Mar 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$155k 210,000 shares
$0.74
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
President And CEO
Holding Value $8.86M 5,335,433 shares
Last Trade
Aug 16, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4k 5,000 shares
$0.80
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
President And CEO
Holding Value $8.85M 5,330,433 shares
Last Trade
May 27, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.9k 5,000 shares
$0.98
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
President And CEO
Holding Value $8.84M 5,325,433 shares
Last Trade
May 20, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6k 10,000 shares
$0.60
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
President And CEO
Holding Value $208k 125,000 shares
Last Trade
Mar 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$134k 125,000 shares
$1.07
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
President And CEO
Holding Value $208k 125,000 shares
Last Trade
Mar 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$134k 125,000 shares
$1.07
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
10% owner, President And CEO
Holding Value $8.82M 5,315,433 shares
Last Trade
Jan 03, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$36.1k 21,853 shares
$1.65
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
10% owner, President And CEO
Holding Value $0 0 shares
Last Trade
Jan 03, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$36.1k 21,853 shares
$1.65
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
10% owner, President And CEO
Holding Value $39.2k 23,589 shares
Last Trade
Nov 17, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$46.5k 23,589 shares
$1.97
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
10% owner, President And CEO
Holding Value $0 0 shares
Last Trade
Aug 17, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$44.1k 21,853 shares
$2.02
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
10% owner, President And CEO
Holding Value $8.79M 5,293,580 shares
Last Trade
Aug 17, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$44.1k 21,853 shares
$2.02
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
10% owner, President And CEO
Holding Value $8.75M 5,271,727 shares
Last Trade
May 14, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$77.7k 16,918 shares
$4.59
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
10% owner, President And CEO
Holding Value $0 0 shares
Last Trade
May 14, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$201k 43,707 shares
$4.59
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
10% owner, President And CEO
Holding Value $8.78M 5,288,645 shares
Last Trade
May 14, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$201k 43,707 shares
$4.59
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
10% owner, President And CEO
Holding Value $166k 100,000 shares
Last Trade
Dec 22, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
10% owner, President And CEO
Holding Value $8.71M 5,244,938 shares
Last Trade
Dec 22, 2020 Sale
No data
No data
$1.66

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up